Drugs and Devices Synergy : PCR clinical algorithms
The Drugs and devices synergy programmed at EuroPCR 2018 included four case-based collaborative sessions, devoted to addressing a single common clinical conundrum in the field of drug-device interactions. These sessions, involving recognised international experts, led to a simple “PCR clinical algorithm”, endorsed by each expert and built in co-operation with the audience.
PCR algorithms do not represent a guideline or the view of any scientific society
- What is the optimal duration of DAPT post-stenting?
- How to manage triple antithrombotic therapy?
- What is the optimal antithrombotic cocktail after TAVI?
- How to handle switching between antiplatelet agents?
Related content
- Towards Drugs and Devices Synergy. A new session track at EuroPCR: PCR clinical algorithms, Philippe Gabriel Steg; William Wijns